Donald Trump holds up a signed executive order in the South Court Auditorium in the White House complex on Friday, July 24, 2020 (AP Photo/Alex Brandon)
July 24, 2020 06:04 PM EDTUpdated 06:52 PM
Pharma

Trump looks to ham­mer down drug prices with 4 ex­ec­u­tive or­ders

Max Gelman

Senior Editor

Pres­i­dent Don­ald Trump signed 4 ex­ec­u­tive or­ders tar­get­ing the phar­ma­ceu­ti­cal in­dus­try Fri­day af­ter­noon, four months be­fore vot­ers head to the polls.

The pres­i­den­tial di­rec­tives are …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times